| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 106.986 | 826.980 | 487.054 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 106.986 | 840.295 | 492.544 | -1.703 |
| Total Expenses - EUR | - | - | - | - | - | - | 743 | 54.037 | 47.988 | 15.181 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 106.242 | 786.258 | 444.556 | -16.885 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 103.097 | 769.288 | 440.361 | -16.885 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Fiv Athens Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 106.855 | 804.530 | 639.834 | 47.835 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 9.984 | 458.793 | 49.760 | 36.115 |
| Cash | - | - | - | - | - | - | 96.871 | 345.737 | 590.074 | 11.720 |
| Shareholders Funds | - | - | - | - | - | - | 103.140 | 769.339 | 620.488 | 39.352 |
| Social Capital | - | - | - | - | - | - | 42 | 43 | 42 | 42 |
| Debts | - | - | - | - | - | - | 3.715 | 35.221 | 19.434 | 8.483 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Fiv Athens Medical S.r.l.